🇺🇸 FDA

Intelligence Platform

Patents

Browse 311 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7247716

Recombinant sequence, its preparation and use

University College Cardiff Consultants Limited · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7227010

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7220419

Self-assembling recombinant papillomavirus capsid proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7214787

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7211432

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7201902

Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella ba

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192593

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection an

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189393

Recombinant anti-tumor RNAse

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7150875

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118738

Recombinant pox virus for immunization against MUC1 tumor-associated antigen

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7081529

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060466

Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene

The Board of Regents of the University of Oklahoma · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056501

Recombinant neospora antigens and their uses

The Regents of the University of California · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7045313

Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccin

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7045136

Methods of immunization using recombinant poxviruses having foreign DNA expressed under th

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7037680

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use

The United States of America as represented by the Secretary of the Army · Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7033750

Recombinant P53 adenovirus methods and compositions

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7015024

Compositions containing recombinant poxviruses having foreign DNA expressed under the cont

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6998252

Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulato

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6979451

Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine

The Board of Regents for Oklahoma State University · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6969609

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America as represented by the Department of Health and Human Serivces · Granted Tue Nov 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6943153

Use of recombinant gene delivery vectors for treating or preventing diseases of the eye

The Regents of the University of California · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6939549

Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and me

The Board of Regents for Oklahoma State University · Granted Tue Sep 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired